Pancreatic Neuroendocrine Carcinoma

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: Multicenter Trial of ESK981 in Patients With Select Solid Tumors [Phase 2]

  This document reports a Phase 2 multicenter clinical trial of ESK981 in select solid tumors. The study is currently recruiting across specif…

• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas [Phase 2]

  A Phase 2 trial comparing cisplatin/etoposide to temozolomide/capecitabine in patients with advanced poorly differentiated gastrointestinal …

• CLINICAL_TRIALS research · 2026-03-09
  Clinical Trial Update: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

  A Mayo Clinic-sponsored clinical trial update recruiting to collect medical information and tissue samples from patients with pancreatic can…

• CLINICAL_TRIALS research · 2025-04-02
  Clinical Trial Update: Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 2]

  Phase 2 clinical trial evaluating a capecitabine-temozolomide combination versus Lutetium-177 dotatate in patients with advanced pancreatic …

• CLINICAL_TRIALS trial_result · 2023-12-19
  Clinical Trial Update: Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin [Phase 2]

  Phase 2 trial evaluating liposomal irinotecan with fluorouracil and leucovorin in patients with refractory advanced high-grade neuroendocrin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-04-01
  Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer [Phase 2]

  Phase 2 trial investigating pazopanib hydrochloride in advanced neuroendocrine tumors; results completed and posted in 2015.